Evolution of treatment for diabetic nephropathy: historical progression from RAAS inhibition and onward.

Item

http://www.wikidata.org/entity/Q37959165

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Evolution of treatment for dia ...... om RAAS inhibition and onward.

@en

Evolution of treatment for dia ...... om RAAS inhibition and onward.

@nl

type

Item

label

Evolution of treatment for dia ...... om RAAS inhibition and onward.

@en

Evolution of treatment for dia ...... om RAAS inhibition and onward.

@nl

prefLabel

Evolution of treatment for dia ...... om RAAS inhibition and onward.

@en

Evolution of treatment for dia ...... om RAAS inhibition and onward.

@nl

P1476

Evolution of treatment for dia ...... om RAAS inhibition and onward.

@en

P2093

Samuel S Blumenthal

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

Renal catabolism of advanced glycation end products: the fate of pentosidine

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Effects of intensive glucose lowering in type 2 diabetes

P304

166-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3810/PGM.2011.11.2506

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22104465

http://www.w3.org/2001/XMLSchema#string